
Investment Amount
- Up to $5m per company (tranched)

Investment Structure
- Syndicated co-investment – equity or convertible debt

Company Profile
- Series A / B or late seed stage high growth opportunities
- Willing to lead roll up of compelling adjacent assets

Geography & Strategic Focus
Located in Virginia or outside Virginia with a connection to Virginia Tech or Carilion Clinic
- Flexible focus on greater Central and Southwest Virginia
Industry Focus
- Life Sciences – Biopharmaceuticals, pharmaceuticals, medical technology & devices, biotechnology
- Technology / Food & Ag – Disruptive technology, IT, or tech-enabled services; engineering, advanced materials, advanced chemicals
Company Attributes
- Experienced management teams, demonstrated traction and results, large addressable market, innovative tech / intellectual property, tangible exit pathways, potential for rapid growth, and executable business model
Mission
While Fund’s primary focus is superior risk-adjusted returns within the venture capital asset class, the intended and desired consequence of investing in high growth companies in Virginia includes, but is not limited to, the following:
- Enhance and diversify the economic base in the Roanoke and New River Valleys by fostering the creation and retention of high growth businesses and jobs.
- Promote entrepreneurship and encourage the development and growth of a vibrant regional entrepreneurial community.
- Facilitate the private sector commercialization of promising technology from Virginia Tech and Carilion.
- Attract investments from regional and national venture capital firms.
- Foster public and private partnerships within the region.